GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: TransCon CNP
Compound class:
Peptide
Comment: Navepegritide (TransCon CNP) is a prodrug of a human C-type natriuretic peptide (CNP) analogue [1]. It comprises CNP(1-38) attached to an inert polyethylene glycol carrier via a cleavable linker [3]. CNP is a validated therapeutic agent for the treatment of patients with achondroplasia (see the approved CNP analogue vosoritide) [2]. Navepegritide is designed to provide sustained hormone release and continuous CNP exposure as a once-weekly therapy that is proposed to counterbalance the overactivated FGFR3 signaling pathway in achondroplasia [1].
|
Classification ![]() |
|
| Compound class | Peptide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 11981 | navepegritide |
Synonyms ![]() |
| TransCon CNP |
Database Links ![]() |
|
| Search PubMed clinical trials | navepegritide |
| Search PubMed titles | navepegritide |
| Search PubMed titles/abstracts | navepegritide |